TTRX – turn therapeutics inc. (US:NASDAQ)
Stock Stats
News
Turn Therapeutics to Present at Upcoming TD Cowen and Oppenheimer Healthcare Conferences [Yahoo! Finance]
Turn Therapeutics to Present at Upcoming TD Cowen and Oppenheimer Healthcare Conferences
Turn Therapeutics (NASDAQ:TTRX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $8.00 price target on the stock.
Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference
Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors
Form 8-K Turn Therapeutics Inc. For: Feb 09
Form 4 Turn Therapeutics Inc. For: Jan 07 Filed by: Dewhurst Martin William
Form 3 Turn Therapeutics Inc. For: Jan 07 Filed by: Dewhurst Martin William
Form 8-K Turn Therapeutics Inc. For: Jan 12
Form 8-K Turn Therapeutics Inc. For: Jan 07
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.